Page 2 - CANNABIDIOL (CBD) Critical Review Report Geneva, 4-7 June 2018 World Health Organization

© World Health Organization 2018

All rights reserved.

th
This is an advance copy distributed to the participants of the 40 Expert Committee
on Drug Dependence, before it has been formally published by the World Health
Organization. The document may not be reviewed, abstracted, quoted, reproduced,
transmitted, distributed, translated or adapted, in part or in whole, in any form or by
any means without the permission of the World Health Organization.

The designations employed and the presentation of the material in this
publication do not imply the expression of any opinion whatsoever on the part of
the World Health Organization concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate
border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does
not imply that they are endorsed or recommended by the World Health
Organization in preference to others of a similar nature that are not mentioned.
Errors and omissions excepted, the names of proprietary products are
distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained
in this publication is complete and correct and shall not be liable for any damages
incurred as a result of its use.